BLCM logo

Bellicum Pharmaceuticals (BLCM) Retained Earnings

Annual Retained Earnings

-$575.42 M
-$24.97 M-4.54%

December 31, 2022


Summary


Performance

BLCM Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLCMbalance sheetmetrics:

Quarterly Retained Earnings

-$591.61 M
-$763.00 K-0.13%

September 1, 2023


Summary


Performance

BLCM Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherBLCMbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

BLCM Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-4.5%-3.9%
3 y3 years-8.0%-5.7%
5 y5 years-78.4%-50.4%

BLCM Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+4.5%at low+7.5%at low
5 y5-year+8.0%at low+14.8%at low
alltimeall time+2638.8%at low+1941.5%at low

Bellicum Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2023
-
-$591.61 M(+0.1%)
Jun 2023
-
-$590.84 M(+1.3%)
Mar 2023
-
-$583.49 M(+1.4%)
Dec 2022
-$575.42 M(+4.5%)
-$575.42 M(+1.1%)
Sep 2022
-
-$569.23 M(+1.3%)
Jun 2022
-
-$562.01 M(+0.7%)
Mar 2022
-
-$558.01 M(+1.4%)
Dec 2021
-$550.45 M(+1.8%)
-$550.45 M(-0.5%)
Sep 2021
-
-$552.98 M(-0.2%)
Jun 2021
-
-$554.22 M(+0.4%)
Mar 2021
-
-$552.01 M(+2.1%)
Dec 2020
-$540.75 M(+1.4%)
-$540.75 M(-3.4%)
Sep 2020
-
-$559.53 M(+0.2%)
Jun 2020
-
-$558.64 M(+8.4%)
Mar 2020
-
-$515.45 M(-3.3%)
Dec 2019
-$533.02 M(+26.7%)
-$533.02 M(+5.7%)
Sep 2019
-
-$504.04 M(+6.8%)
Jun 2019
-
-$472.01 M(+6.1%)
Mar 2019
-
-$445.08 M(+5.8%)
DateAnnualQuarterly
Dec 2018
-$420.55 M(+30.4%)
-$420.55 M(+6.9%)
Sep 2018
-
-$393.33 M(+6.4%)
Jun 2018
-
-$369.53 M(+7.0%)
Mar 2018
-
-$345.35 M(+7.1%)
Dec 2017
-$322.51 M(+39.8%)
-$322.51 M(+7.3%)
Sep 2017
-
-$300.59 M(+8.5%)
Jun 2017
-
-$277.16 M(+9.7%)
Mar 2017
-
-$252.71 M(+9.5%)
Dec 2016
-$230.73 M(+42.9%)
-$230.73 M(+9.5%)
Sep 2016
-
-$210.79 M(+9.2%)
Jun 2016
-
-$193.08 M(+9.3%)
Mar 2016
-
-$176.57 M(+9.3%)
Dec 2015
-$161.49 M(+43.0%)
-$161.49 M(+11.6%)
Sep 2015
-
-$144.64 M(+10.2%)
Jun 2015
-
-$131.24 M(+8.7%)
Mar 2015
-
-$120.70 M(+6.9%)
Dec 2014
-$112.94 M(+289.7%)
-$112.94 M(+192.3%)
Sep 2014
-
-$38.65 M(+33.4%)
Dec 2013
-$28.98 M(+37.9%)
-$28.98 M
Dec 2012
-$21.01 M
-

FAQ

  • What is Bellicum Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals annual retained earnings year-on-year change?
  • What is Bellicum Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Bellicum Pharmaceuticals?
  • What is Bellicum Pharmaceuticals quarterly retained earnings year-on-year change?

What is Bellicum Pharmaceuticals annual retained earnings?

The current annual retained earnings of BLCM is -$575.42 M

What is the all time high annual retained earnings for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high annual retained earnings is -$21.01 M

What is Bellicum Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, BLCM annual retained earnings has changed by -$24.97 M (-4.54%)

What is Bellicum Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of BLCM is -$591.61 M

What is the all time high quarterly retained earnings for Bellicum Pharmaceuticals?

Bellicum Pharmaceuticals all-time high quarterly retained earnings is -$28.98 M

What is Bellicum Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, BLCM quarterly retained earnings has changed by -$22.38 M (-3.93%)